Linked Life Data

20444749

Source:http://linkedlifedata.com/resource/pubmed/id/20444749

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-5-25
pubmed:abstractText
To evaluate the efficacy and safety of golimumab to 52 weeks in patients with active rheumatoid arthritis despite methotrexate.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1468-2060
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1129-35
pubmed:dateRevised
2011-1-3
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study.
pubmed:affiliation
University of Toronto and Mount Sinai Hospital, 60 Murray Street, 2nd Floor, Room 2-006, Toronto, Ontario M5G 1X5, Canada. edkeystone@mtsinai.on.ca
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't